Subscribe To
Tango therapeutics: partial phase 1 data has not helped
In my previous article, I hoped that Tango publishing POC data would help the stock. They published partial data, and it was not convincing. The stock...
July 26, 2023, 7:29 pm
Strong large-cap insider buys: q2 2023
After bringing you the second quarter installment covering mid-cap corporate insider activity, today's piece article will cover on the latest insider ...
July 26, 2023, 2:48 pm
Fireweed metals hails first assay results from 2023 exploration at macmillan pass project in yukon
Fireweed Metals Corp (TSX-V:FWZ, OTCQB:FWEDF) described the first assay results from its 2023 exploration at the Macmillan Pass Project in Yukon as�...
July 26, 2023, 8:18 am
Gbp/usd seems to have moved into a consolidative phase – uob
GBP/USD is holding the renewed uptick at around 1.2900 in early Europe this Wednesday. The US Dollar is on the defensive, despite a cautious market mo...
July 26, 2023, 7:14 am
Merck and moderna launch late-stage trial of v940 with keytruda as treatment for high-risk melanoma
Merck & Co. MRK, -1.16% and Moderna Inc. MRNA, -0.93% said Wednesday they have launched a phase 3 trial...
July 26, 2023, 6:55 am
Enphase energy: market misunderstanding is your opportunity
Enphase Energy's share price has fallen 47% from its high, despite increased earnings per share expecta...
July 25, 2023, 10:45 pm
Enphase energy: hypergrowth in europe likely to continue for few more years
Enphase Energy, Inc.'s strong balance sheet and growth outlook, particularly in Europe, make it an attr...
July 25, 2023, 2:51 pm
Kodiak (kod) down as late-stage dme studies fail
Kodiak (KOD) stock plunges as it failed to meet the primary endpoint in phase III studies evaluating ta...
July 25, 2023, 10:53 am
Elevar therapeutics announces publication of phase 3 cares 310 study results in the lancet
In CARES 310, camrelizumab plus rivoceranib demonstrated statistically significant and clinically meaningful prolonged overall survival and progressio...
July 25, 2023, 1:39 am
Gossamer bio to hold conference call with pah experts to discuss prosera phase 3 design and interim torrey ole results
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercializa...
July 24, 2023, 4:16 pm
Why is paxmedica (pxmd) stock up today?
Clinical-stage biopharmaceutical firm PaxMedica (NASDAQ: PXMD ) is experiencing a full range of emotions following an initial spike in the market toda...
July 24, 2023, 2:17 pm
Kodiak sciences discontinues development of eye disorder therapeutic; shares plummet
Kodiak Sciences shares fell by more than 45% after the biopharmaceutical company announced that it was discontinuing its tarcocimab program for eye di...
July 24, 2023, 1:59 pm
Gilead (gild) ends myelodysplastic syndromes study on magrolimab
Gilead Sciences, Inc. (GILD) discontinues phase III ENHANCE study, evaluating the potential of magrolim...
July 24, 2023, 12:20 pm
Annexon to report archer phase 2 trial results in geographic atrophy at asrs 2023
Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ET BRISBANE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — ...
July 24, 2023, 10:30 am
Gilead sciences shares decline after it discontinues blood cancer treatment trial
Gilead Sciences, Inc. (NASDAQ:GILD) started on the back foot on Monday after the biopharmaceutical company told investors it has discontinued its
July 24, 2023, 10:27 am
Enphase energy (enph) to post q2 earnings: what's in store?
Enphase Energy's (ENPH) Q2 results are likely to benefit from the increased shipments of microinverters...
July 24, 2023, 10:06 am
Belite bio completes enrollment in pivotal global phase 3 dragon trial evaluating oral tinlarebant for stargardt disease
Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in patients with Stargardt Disease (STGD...
July 24, 2023, 10:04 am
Don't buy rolls-royce shares: buy ge stock if you can
Rolls-Royce (LON: RR) share price has been in a consolidation phase for a while, as I wrote in this art...
July 24, 2023, 6:25 am
Gold price forecast: xau/usd appears ‘buy-the-dips’ trade kicking off a big week
Gold price is nursing losses while defending $1,950 early Monday, pausing last week’s three-day downtrend. The United States Dollar (USD) has entere...
July 24, 2023, 4:59 am
Dollar turned into consolidation phase as selling passed climax
Dollar recovered broadly last week and it seemed to have emerged from its near-term selling climax. While it’s premature to call for bullish trend r...
July 22, 2023, 2:04 pm